Drugs Made In America Acquisition II Corp. Unit
Drugs Made In America Acquisition II Corp. Unit
Share · KYG2851K1206 · DMIIU (XNAS)
Overview
No Price
12.12.2025 19:33
Current Prices from Drugs Made In America Acquisition II Corp. Unit
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
DMIIU
USD
12.12.2025 19:33
10,01 USD
0,010 USD
+0,10 %
Share Float & Liquidity
Free Float 93,08 %
Shares Float 58,66 M
Shares Outstanding 63,02 M
Company Profile for Drugs Made In America Acquisition II Corp. Unit Share
A SPAC (blank check company) incorporated in the Cayman Islands to pursue a business combination. The company aims to focus on pharmaceutical / drug sector targets to reduce U.S. reliance on global drug manufacturing. Each unit consists of one ordinary share and one right to receive one-tenth of a share upon completion of a qualifying business combination.
Get up to date insights from finAgent about Drugs Made In America Acquisition II Corp. Unit

Company Data

Name Drugs Made In America Acquisition II Corp. Unit
Company Drugs Made In America Acquisition II Corp. Unit
Symbol DMIIU
Primary Exchange XNAS NASDAQ
ISIN KYG2851K1206
Asset Class Share
Sector Financial Services
Industry Asset Management
CEO Lynn Stockwell
Market Capitalization 631 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 1 East Broward Boulevard, 33301 Fort Lauderdale
IPO Date 2025-09-25

Ticker Symbols

Name Symbol
NASDAQ DMIIU
More Shares
Investors who hold Drugs Made In America Acquisition II Corp. Unit also have the following shares in their portfolio:
BOTT./CBC/B. 22/29 REGS
BOTT./CBC/B. 22/29 REGS Bond
POLEN 15-26 FLR
POLEN 15-26 FLR Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025